North American metered dose inhaler market was $2.9 billion in 2018 and is anticipated to grow at a substantial rate of 2.2% during the forecast period. The major factors that are contributing significantly in the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The US and Canada are the major economies of North America. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of metered dose inhaler market in North America region. The increasing demand for inhaler due to increasing COPD and asthma patients in the US have endorsed the approval of cohesive reimbursement policies in the US, is further fueling the growth of the market. The US is the major market due to greater healthcare expenditure and higher prevalence rate of respiratory diseases.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/north-american-metered-dose-inhaler-market
The North American metered dose inhaler market is segmented on the basis of type, application, and end-user. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Preventive metered dose inhaler segment led the global metered dose inhaler market in 2018. The preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in market include Budesonide and Fluticasone. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/north-american-metered-dose-inhaler-market
Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing metered dose inhaler to cater to a wide range of customers within the region and across the globe. The major players of the North American inhaler market include 3M Co., AstraZeneca PLC, Aradigm Corp., Adherium Ltd., GlaxoSmithKline PLC, Novartis AG, ResMed Corp. (Propeller Health), Teva Pharmaceuticals Industries Ltd. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.
• North American Metered Dose Inhaler Market by Type
• Long Acting Bronchodilators
• North American Metered Dose Inhaler Market by Application
• Chronic Obstructive Pulmonary Disease (COPD)
• North American Metered Dose Inhaler Market by End-User
• Hospitals and Clinics
• 3M Co.
• Acorda Therapeutics, Inc.
• Adamis Pharmaceuticals Corp.
• Adherium Ltd.
• Aradigm Corp.
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Drive Devilbiss Healthcare LLC
• GlaxoSmithKline PLC
• Koninklijke Philips N.V.
• Manta Devices LLC
• Novartis AG
• Omron Healthcare Inc.
• ResMed Corp.
• Pulmatrix Inc.
• Savara, Inc.
• Sunovion Pharmaceuticals
• Teva Pharmaceuticals Industries Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-metered-dose-inhaler-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404